TITAN PHARMACEUTICALS INC·4

Feb 11, 6:26 AM ET

Rubin Marc 4

4 · TITAN PHARMACEUTICALS INC · Filed Feb 11, 2021

Insider Transaction Report

Form 4
Period: 2021-02-10
Rubin Marc
DirectorExecutive Chairman
Transactions
  • Award

    Option to Purchase Common Stock

    2021-02-10+150,000150,000 total
    Exercise: $4.02Exp: 2031-02-10Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The options vest as to 75,000 shares on August 10, 2021 with the balance to vest in equal monthly installments over the 18 months thereafter.

Documents

1 file
  • 4
    tm216217-5_4.xmlPrimary

    OWNERSHIP DOCUMENT